{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T10:55:07Z","timestamp":1789815307683,"version":"4.0.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1007\/s00125-009-1418-4","type":"journal-article","created":{"date-parts":[[2009,6,29]],"date-time":"2009-06-29T13:58:27Z","timestamp":1246283907000},"page":"1732-1744","source":"Crossref","is-referenced-by-count":501,"title":["Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study"],"prefix":"10.1007","volume":"52","author":[{"given":"L. G.","family":"Hemkens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Grouven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Bender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"G\u00fcnster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Gutschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. W.","family":"Selke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. T.","family":"Sawicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,6,30]]},"reference":[{"key":"1418_CR1","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/jnci\/94.13.972","volume":"94","author":"MS Sandhu","year":"2002","unstructured":"Sandhu MS, Dunger DB, Giovannucci EL (2002) Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. J Natl Cancer Inst 94:972\u2013980","journal-title":"J Natl Cancer Inst"},{"key":"1418_CR2","first-page":"1013","volume":"5","author":"TT Tran","year":"1996","unstructured":"Tran TT, Medline A, Bruce WR (1996) Insulin promotion of colon tumors in rats. Cancer Epidemiol Biomarkers Prev 5:1013\u20131015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1418_CR3","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/ijc.22717","volume":"121","author":"SC Larsson","year":"2007","unstructured":"Larsson SC, Mantzoros CS, Wolk A (2007) Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 121:856\u2013862","journal-title":"Int J Cancer"},{"key":"1418_CR4","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1007\/s00125-006-0468-0","volume":"49","author":"SC Larsson","year":"2006","unstructured":"Larsson SC, Orsini N, Brismar K, Wolk A (2006) Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia 49:2819\u20132823","journal-title":"Diabetologia"},{"key":"1418_CR5","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1093\/jnci\/dji375","volume":"97","author":"SC Larsson","year":"2005","unstructured":"Larsson SC, Orsini N, Wolk A (2005) Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 97:1679\u20131687","journal-title":"J Natl Cancer Inst"},{"key":"1418_CR6","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1038\/sj.bjc.6602619","volume":"92","author":"R Huxley","year":"2005","unstructured":"Huxley R, Ansary-Moghaddam A, Berrington de Gonz\u00e1lez A, Barzi F, Woodward M (2005) Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 92:2076\u20132083","journal-title":"Br J Cancer"},{"key":"1418_CR7","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s00125-007-0681-5","volume":"50","author":"E Friberg","year":"2007","unstructured":"Friberg E, Orsini N, Mantzoros CS, Wolk A (2007) Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia 50:1365\u20131374","journal-title":"Diabetologia"},{"key":"1418_CR8","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1053\/j.gastro.2004.07.011","volume":"127","author":"YX Yang","year":"2004","unstructured":"Yang YX, Hennessy S, Lewis JD (2004) Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology 127:1044\u20131050","journal-title":"Gastroenterology"},{"key":"1418_CR9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF00405001","volume":"34","author":"KE Bornfeldt","year":"1991","unstructured":"Bornfeldt KE, Gidl\u00f6f RA, Wasteson A, Lake M, Skottner A, Arnqvist HJ (1991) Binding and biological effects of insulin, insulin analogues and insulin-like growth factors in rat aortic smooth muscle cells. Comparison of maximal growth promoting activities. Diabetologia 34:307\u2013313","journal-title":"Diabetologia"},{"key":"1418_CR10","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2337\/diabetes.49.6.999","volume":"49","author":"P Kurtzhals","year":"2000","unstructured":"Kurtzhals P, Sch\u00e4ffer L, S\u00f8rensen A et al (2000) Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes 49:999\u20131005","journal-title":"Diabetes"},{"key":"1418_CR11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/13813450801900645","volume":"114","author":"D Mayer","year":"2008","unstructured":"Mayer D, Shukla A, Enzmann H (2008) Proliferative effects of insulin analogues on mammary epithelial cells. Arch Physiol Biochem 114:38\u201344","journal-title":"Arch Physiol Biochem"},{"key":"1418_CR12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/dmrr.912","volume":"25","author":"D Weinstein","year":"2009","unstructured":"Weinstein D, Simon M, Yehezkel E, Laron Z, Werner H (2009) Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activities in cultured cancer cells. Diabetes Metab Res Rev 25:41\u201349","journal-title":"Diabetes Metab Res Rev"},{"key":"1418_CR13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/dmr.5610080305","volume":"8","author":"KK Drejer","year":"1992","unstructured":"Drejer KK, S\u00f8rensen AR, Wiberg FC, Klein HH, Lundemose AG (1992) The bioactivity of insulin analogues from in vitro receptor binding to in vivo glucose uptake. Diabetes Metab Rev 8:259\u2013285","journal-title":"Diabetes Metab Rev"},{"key":"1418_CR14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/10915810290096306","volume":"21","author":"I Stammberger","year":"2002","unstructured":"Stammberger I, Bube A, Durchfeld-Meyer B, Donaubauer H, Troschau G (2002) Evaluation of the carcinogenic potential of insulin glargine (LANTUS) in rats and mice. Int J Toxicol 21:171\u2013179","journal-title":"Int J Toxicol"},{"key":"1418_CR15","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0140-6736(01)05842-1","volume":"358","author":"DR Owens","year":"2001","unstructured":"Owens DR, Zinman B, Bolli GB (2001) Insulins today and beyond. Lancet 358:739\u2013746","journal-title":"Lancet"},{"key":"1418_CR16","unstructured":"Institut f\u00fcr Qualit\u00e4t und Wirtschaftlichkeit im Gesundheitswesen (2007) Kurzwirksame Insulinanaloga zur Behandlung des Diabetes mellitus Typ 1: Abschlussbericht; Auftrag A05-02. [Rapid-acting insulin analogues for the treatment of diabetes mellitus type 1: final report A05-02.] Available from www.iqwig.de\/download\/A05-02_Abschlussbericht_Kurzwirksame_Insulinanaloga_bei_Diabetes_mellitus_Typ_1.pdf . Accessed 20 March 2009 (article in German)"},{"key":"1418_CR17","unstructured":"Institut f\u00fcr Qualit\u00e4t und Wirtschaftlichkeit im Gesundheitswesen (2005) Kurzwirksame Insulinanaloga zur Behandlung des Diabetes mellitus Typ 2: Abschlussbericht; Auftrag A05-04. [Rapid-acting insulin analogues for the treatment of diabetes mellitus type 2: final report A05-04.] Available from www.iqwig.de\/download\/A05-04_Abschlussbericht_Kurzwirksame_Insulinanaloga_bei_Typ_2_Diabetes_mellitus.pdf . Accessed 20 March 2009 (article in German)"},{"key":"1418_CR18","unstructured":"Institut f\u00fcr Qualit\u00e4t und Wirtschaftlichkeit im Gesundheitswesen (2009) Langwirksame Insulinanaloga zur Behandlung des Diabetes mellitus Typ 2: Abschlussbericht; Auftrag A05-03. [Long-acting insulin analogues for the treatment of diabetes mellitus type 2: final report A05-03.] Available from www.iqwig.de\/download\/A05-03_Abschlussbericht_Langwirksame_Insulinanaloga_bei_Diabetes_mellitus_Typ_2_V1.1.pdf . Accessed 20 March 2009 (article in German)"},{"key":"1418_CR19","unstructured":"Fricke U, G\u00fcnther J, Zawinell A (2007) Anatomisch-therapeutisch-chemische Klassifikation mit Tagesdosen f\u00fcr den deutschen Arzneimittelmarkt. Methodik der ATC-Klassifikation und der DDD-Festlegung. ATC-Index mit DDD-Angaben. [The Anatomical Therapeutic Classification with daily doses for the German pharmaceutical market. Methodology of the ATC classification and DDD specification. ATC index with DDD information.] Available from http:\/\/wido.de\/fileadmin\/wido\/downloads\/pdf_arzneimittel\/wido_arz_atc-index_0406.pdf . Accessed 20 March 2009 (article in German)"},{"key":"1418_CR20","volume-title":"Applied survival analysis","author":"DW Hosmer","year":"1999","unstructured":"Hosmer DW, Lemeshow S (1999) Applied survival analysis. Wiley, New York"},{"key":"1418_CR21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR (1972) Regression models and life tables (with discussion). J R Stat Soc Ser B 34:187\u2013220","journal-title":"J R Stat Soc Ser B"},{"key":"1418_CR22","doi-asserted-by":"crossref","DOI":"10.1007\/0-387-29150-4","volume-title":"Survival analysis. A self-learning text","author":"DG Kleinbaum","year":"2005","unstructured":"Kleinbaum DG, Klein M (2005) Survival analysis. A self-learning text, 2nd edn. Springer, New York","edition":"2"},{"key":"1418_CR23","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0895-4356(00)00314-0","volume":"54","author":"R Bender","year":"2001","unstructured":"Bender R, Lange S (2001) Adjusting for multiple testing\u2014when and how? J Clin Epidemiol 54:343\u2013349","journal-title":"J Clin Epidemiol"},{"key":"1418_CR24","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","volume":"330","author":"JM Evans","year":"2005","unstructured":"Evans JM, Donnelly LA, Emslie-Smith AM, Alessi DR, Morris AD (2005) Metformin and reduced risk of cancer in diabetic patients. BMJ 330:1304\u20131305","journal-title":"BMJ"},{"key":"1418_CR25","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1007\/s00125-002-0957-8","volume":"45","author":"I M\u00fchlhauser","year":"2002","unstructured":"M\u00fchlhauser I, Sawicki PT, Blank M, Overmann H, Richter B, Berger M (2002) Reliability of causes of death in persons with type I diabetes. Diabetologia 45:1490\u20131497","journal-title":"Diabetologia"},{"key":"1418_CR26","unstructured":"Horvath K, Jeitler K, Berghold A et al (2007) Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus. Cochrane Database Syst Rev (2):CD005613. doi: 10.1002\/14651858.CD005613.p"},{"key":"1418_CR27","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1503\/cmaj.081041","volume":"180","author":"SR Singh","year":"2009","unstructured":"Singh SR, Ahmad F, Lal A, Yu C, Bai Z, Bennett H (2009) Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis. CMAJ 180:385\u2013397","journal-title":"CMAJ"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-009-1418-4.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T13:46:16Z","timestamp":1739195176000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-009-1418-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,30]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["1418"],"URL":"https:\/\/doi.org\/10.1007\/s00125-009-1418-4","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,30]]}}}